Paperpal Prime Logo

Statistics in Biopharmaceutical Research : Impact Factor & More

eISSN: 1946-6315pISSN: 1946-6315

Key Metrics

CiteScore
2.5
Impact Factor
< 5
SJR
Q3Pharmaceutical Science
SNIP
0.9
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Statistics in Biopharmaceutical Research

Statistics in Biopharmaceutical Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS INC
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Statistics in Biopharmaceutical Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Statistics in Biopharmaceutical Research

Evaluating Time-Varying and Heterogeneous Efficacy of COVID-19 Antiviral Drugs
  • 23 Jul 2026
  • Statistics in Biopharmaceutical Research
Aligning Estimands to Strengthen the Credibility of Network Meta-Analysis: Implications for Indirect Treatment Comparisons
  • 21 Jul 2026
  • Statistics in Biopharmaceutical Research
A Bayesian Design with Efficient Backfilling and Expansion to Accelerate Phase I/II Trials Accommodating Late-Onset Competing Risk Outcomes
  • 18 Jul 2026
  • Statistics in Biopharmaceutical Research
Targeted Learning for Tilted Average Treatment Effects
  • 18 Jul 2026
  • Statistics in Biopharmaceutical Research
Doubly Robust Estimation of Desirability of Outcome Ranking (DOOR) Probability with Application to MDRO Studies
  • 7 Jul 2026
  • Statistics in Biopharmaceutical Research
BOOST: An Adaptive Biomarker-Guided Simon Two-Stage Design with Explicit Control of Pooled and Subgroup Inference
  • 6 Jul 2026
  • Statistics in Biopharmaceutical Research
Evaluating Time-Varying and Heterogeneous Efficacy of COVID-19 Antiviral Drugs
  • 23 Jul 2026
  • Statistics in Biopharmaceutical Research
Aligning Estimands to Strengthen the Credibility of Network Meta-Analysis: Implications for Indirect Treatment Comparisons
  • 21 Jul 2026
  • Statistics in Biopharmaceutical Research
A Bayesian Design with Efficient Backfilling and Expansion to Accelerate Phase I/II Trials Accommodating Late-Onset Competing Risk Outcomes
  • 18 Jul 2026
  • Statistics in Biopharmaceutical Research
Targeted Learning for Tilted Average Treatment Effects
  • 18 Jul 2026
  • Statistics in Biopharmaceutical Research
Doubly Robust Estimation of Desirability of Outcome Ranking (DOOR) Probability with Application to MDRO Studies
  • 7 Jul 2026
  • Statistics in Biopharmaceutical Research
BOOST: An Adaptive Biomarker-Guided Simon Two-Stage Design with Explicit Control of Pooled and Subgroup Inference
  • 6 Jul 2026
  • Statistics in Biopharmaceutical Research

FAQs on Statistics in Biopharmaceutical Research